Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Feb 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Option exercise(M)7K$0.06$3907K
Feb 2, 2026Sell(S)7K$3.03$20K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2026Option exercise(M)7K—$0313K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML